Chinese factory activity expanded in December for the first time in eight months, with the official purchasing managers index rising

Pacific Biosciences of California, Inc. (NASDAQ:PACB) is listed among the 12 Best Genomics Stocks to Invest In. Barclays analyst raises

Tempus AI, Inc. (NASDAQ:TEM) is listed among the 12 Best Genomics Stocks to Invest In. Canaccord reduced its price objective

Prime Medicine, Inc. (NASDAQ:PRME) is featured in the 12 Best Genomics Stocks to Invest In. The company announced the New

China is tightening controls on silver exports, affecting industries crucial to the US. Elon Musk criticized the move, calling out

Wall Street closed out 2025 with a downbeat finish, extending a losing streak. S&P 500 fell 0.7%, Dow Jones 0.6%,

Analysts have lowered the target price for ARCB to $79.00. This adjustment reflects changing market conditions and factors affecting the

School Specialty (SCHL) has seen a significant increase in its target price, now up to $31.00. This indicates a positive

SEZL stock faced a downgrade with the target price being lowered to $62.00. Analysts cite concerns over market conditions and

Analysts have lowered the target price for Nutanix Inc. (NTNX) to $49.00. This adjustment reflects a more conservative outlook on

The investment firm BCPC has lowered its target price to $147.00, indicating a potential decrease in the stock’s value. This

Cotton futures closed within 5 points of unchanged. Crude oil futures were down 13 cents at $57.95 per barrel. The

Thermo Fisher Scientific Inc. (NYSE:TMO) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2026. Bank of

Johnson & Johnson (JNJ) ends mid-stage eczema study after missing efficacy bar. The drug JNJ-5939 was well-tolerated but did not

AbbVie Inc. (NYSE:ABBV) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2026. BofA lowered AbbVie’s price

Abbott Laboratories (NYSE: ABT) received FDA approval for its Volt PFA System to treat atrial fibrillation (AFib). AFib affects 12

Amgen Inc. (NASDAQ:AMGN) is one of the “14 Best Pharma Dividend Stocks to Buy in 2026.” The company has seen

In 2025, energy market trends shaped the global oil, gas, and energy equities markets. Geopolitical tensions, supply-demand balances, and challenges

The Coca-Cola Company (NYSE:KO) is among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. BofA raised Coca-Cola’s

Caterpillar Inc. is listed among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. Bernstein raised its price

Automatic Data Processing, Inc. (NASDAQ:ADP) is among the 14 Best Dividend Aristocrats for 2026. Jefferies downgraded ADP to Underperform due

Dover Corporation (NYSE:DOV) has its price target raised to $240 from $225 by BofA analyst Andrew Obin, who sees momentum

Church & Dwight Co., Inc. (NYSE:CHD) is named one of the 14 Best Dividend Aristocrats to Invest in Heading into

Nucor Corp (NYSE:NUE) stock is trading near its one-year high of $168.04, with potential to extend gains. Historical data shows

Kimberly-Clark Corporation (KMB) has been named one of the 14 Best Dividend Aristocrats to invest in for 2026. Citi recently